パルスフィールドアブレーションの世界市場：市場規模・シェア・動向分析 (コンポーネント別・適応症別・最終用途別・地域別・セグメント別、2025年～2030年)

パルスフィールドアブレーションの市場規模と動向：

世界のパルスフィールドアブレーションの市場規模は、2024年に9億1,310万米ドルと推計され、2025年から2030年にかけてCAGR 33.1%で成長すると予測されています。

この背景には、従来の熱アブレーション法に代わる、より安全で効果的な方法として期待されていることがあります。心房細動 (AF) の世界の有病率の上昇に伴い、合併症が少なく治療成績が向上する革新的な治療オプションに対する需要が高まっています。パルスフィールドアブレーション (PFA) の非熱的メカニズムは、高周波やクライオアブレーションのような従来のアブレーション技術の大きな限界であった周辺組織を損傷するリスクを大幅に低減します。このユニークな利点により、ヘルスケアプロバイダーや患者からの関心が高まり、臨床現場での採用が加速しています。

不整脈、特に心房細動 (AF) はますます蔓延しており、世界中で数百万人が罹患しています。心房細動は、不規則でしばしば速い心拍数を特徴とし、持続性不整脈の中で最も一般的なタイプであり、脳卒中、心不全、その他の重篤な心血管系合併症のリスクを著しく高めます。世界の人口が高齢化し、高血圧や肥満などの生活習慣に関連する危険因子の発生率が上昇するにつれて、心房細動の症例数は増加の一途をたどっています。2024年2月に発表されたジョンソン・エンド・ジョンソン・サービス社の記事によると、全世界で3,750万人以上がこの症状を抱えており、その影響が広範囲に及んでいることが強調されています。心房細動の開発リスクは特に高く、統計によると、40歳以上の成人の約4人に1人が、人生のどこかでこの不整脈を経験しています。このような有病率の増加は、効果的な管理と予防戦略の緊急の必要性を浮き彫りにしています。

このような負担の増大により、効果的で侵襲の少ない治療法に対する大きな需要が生じています。抗不整脈薬やカテーテルを用いたアブレーションなどの従来の治療法には限界があり、より安全で効率的なアプローチが求められています。したがって、不整脈の有病率の増加は、従来の方法と比較して安全性プロファイルと有効性が改善されたパルスフィールドアブレーション (PFA) のような先進治療技術の市場成長の主要な促進要因となっています。2024年2月、The Lancet Regional Health-Europeに掲載された論文によると、心房細動 (AF) は欧州の成人の1.5～2%が罹患しており、2060年までに65歳以上で9.5%に増加すると予想されています。心房細動は、脳卒中、認知症、心不全、早期死亡の重大な危険因子であり、高齢化社会とヘルスケアシステムに課題を投げかけています。

技術革新は、アブレーション処置の精度、安全性、有効性を高めるものであり、PFA産業成長の主要な原動力となっています。主要医療機器企業は次世代PFAシステムの開発に多額の投資を行っており、エネルギー供給、カテーテル設計、手技効率の改善に注力しています。カテーテルの柔軟性とリアルタイムの画像化およびマッピング技術の統合における革新は、より的を絞った制御されたアブレーションを可能にし、合併症のリスクを低減し、患者の転帰を改善します。2024年10月、アボット社は電気生理学用のパルスフィールドアブレーション技術における重要な進歩を発表しました。同社は、Volt PFAシステムの評価を目的としたVOLT-AF IDE試験の参加者登録を終了し、発作性心房細動の治療を目的としたTactiFlex Duoアブレーションカテーテルを試験するFOCALFLEX試験を開始しました。これらのイニシアチブは、アボット社のPFAカテーテルにとって大きな進歩を意味します。

規制当局の承認は、PFA業界に影響を与える重要なものであり、これらの新規デバイスの安全性と有効性を検証し、より広範な臨床採用への道を開くものだからです。近年、いくつかのPFAシステムが欧州でCEマーキングを取得し、欧州全域での販売と使用が可能になりました。これらの承認は、特に手技時間の短縮と合併症の減少という点で、従来の方法よりもPFAが優れていることを証明する肯定的な臨床試験結果に基づいていることが多いです。2024年10月、メドトロニックは持続性心房細動と心房粗動の治療用にデザインされたSphere-9カテーテル付きAffera Mapping and Ablation SystemのFDA承認を取得しました。これによりメドトロニック社は、FDAが承認した2つの心房細動用パルスフィールドアブレーション (PFA) 技術を有する最初の企業となった。スフィア-9カテーテルは、9mmの格子状の先端により柔軟な治療オプションを提供し、肺静脈隔離のためのシングルショットソリューションを提供するパルスセレクトPFAシステムを補完します。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 パルスフィールドアブレーション市場：変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• パルスフィールドアブレーション市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析

第4章 パルスフィールドアブレーション市場：コンポーネント別の推定と動向分析

• セグメントダッシュボード
• パルスフィールドアブレーション市場：変動分析、コンポーネント別
• パルスフィールドアブレーション市場の展望：コンポーネント別
• 市場規模の予測と動向分析 (2018～2030年)
• カテーテル
• 発電機

第5章 パルスフィールドアブレーション市場：適応症別の推定と動向分析

• セグメントダッシュボード
• パルスフィールドアブレーション市場：変動分析、適応症別
• パルスフィールドアブレーション市場の展望：適応症別
• 市場規模の予測と動向分析 (2018～2030年)
• 心房細動
• 非心房細動

第6章 パルスフィールドアブレーション市場：最終用途別の推定と動向分析

• セグメントダッシュボード
• パルスフィールドアブレーション市場：変動分析、最終用途別
• パルスフィールドアブレーション市場の展望：最終用途別
• 市場規模の予測と動向分析 (2018～2030年)
• 入院施設
• 外来施設

第7章 パルスフィールドアブレーション市場：地域別の推定と動向分析

• 地域別のダッシュボード
• 市場規模の予測と動向分析 (2018～2030年)
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Boston Scientific Corporation
  • Abbott
  • Medtronic
  • Biosense Webster, Inc. (Johnson &Johnson Services, Inc)
  • Pulse Biosciences, Inc
  • Kardium
  • Jia Jing Electronic Co., Ltd.
  • Adagio Medical Inc
  • CardioFocus
  • Acutus Medical, Inc

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 4 Global pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 5 Global pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 6 North America pulsed field ablation market, by region, 2018 - 2030 (USD Million)
• Table 7 North America pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 8 North America pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 9 North America pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 11 U.S pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 12 U.S pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 14 Canada pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 15 Canada pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 17 Mexico pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 18 Mexico pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe pulsed field ablation market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 21 Europe pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 22 Europe pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 23 UK pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 24 UK pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 25 UK pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 26 Germany pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 27 Germany pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 28 Germany pulsed field ablation market, by end use 2018 - 2030 (USD Million)
• Table 29 France pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 30 France pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 31 France pulsed field ablation market, by end use 2018 - 2030 (USD Million)
• Table 32 Italy pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 33 Italy pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 34 Italy pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 36 Spain pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 37 Spain pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 38 Denmark pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 39 Denmark pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 40 Denmark pulsed field ablation market, by end use 2018 - 2030 (USD Million)
• Table 41 Norway pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 42 Norway pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 43 Norway pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 44 Sweden pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 45 Sweden pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 46 Sweden pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific pulsed field ablation market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 51 Japan pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 52 Japan pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 53 Japan pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 54 China pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 55 China pulsed field ablation market, by indication 2018 - 2030 (USD Million)
• Table 56 China pulsed field ablation market, by end use 2018 - 2030 (USD Million)
• Table 57 India pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 58 India pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 59 India pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 60 Australia pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 61 Australia pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 62 Australia pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 63 South Korea pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 64 South Korea pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 65 South Korea pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 66 Thailand pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 67 Thailand pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 68 Thailand pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 69 Latin America pulsed field ablation market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 71 Latin America pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 72 Latin America pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 73 Brazil pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 74 Brazil pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 75 Brazil pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 77 Argentina pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 78 Argentina pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa pulsed field ablation market, by country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 83 South Africa pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 84 South Africa pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 85 South Africa pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 89 UAE pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 90 UAE pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 91 UAE pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
• Table 92 Kuwait pulsed field ablation market, by components, 2018 - 2030 (USD Million)
• Table 93 Kuwait pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
• Table 94 Kuwait pulsed field ablation market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information procurement
• Fig. 2 Primary research pattern
• Fig. 3 Market research approaches
• Fig. 4 Market formulation & validation
• Fig. 5 Pulsed field ablation market segmentation
• Fig. 6 Market driver analysis (current & future impact)
• Fig. 7 Market restraint analysis (current & future impact)
• Fig. 8 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 9 Porter's five forces analysis
• Fig. 10 Pulsed field ablation market, components outlook key takeaways (USD Million)
• Fig. 11 Pulsed field ablation market: components movement analysis (USD Million), 2024 & 2030
• Fig. 12 Catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 13 Generators market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Pulsed field ablation market, indication outlook key takeaways (USD Million)
• Fig. 15 Pulsed field ablation market: indication movement analysis (USD Million), 2024 & 2030
• Fig. 16 Atrial fibrillation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17 Non-atrial fibrillation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 Pulsed field ablation market, end use outlook key takeaways (USD Million)
• Fig. 19 Pulsed field ablation market: end use movement analysis (USD Million), 2024 & 2030
• Fig. 20 Inpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Pulsed field ablation market: regional key takeaways (USD Million)
• Fig. 23 Pulsed field ablation market: regional outlook, 2024 & 2030, USD Million
• Fig. 24 North America pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 US pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Canada pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Mexico pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Europe pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 UK pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Germany pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 France pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Spain pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Italy pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Norway pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Denmark pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Sweden pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Asia Pacific pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 China pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Japan pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 India pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 South Korea pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Australia pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Thailand pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Latin America pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Brazil pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Argentina pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Middle East and Africa pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 South Africa pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Saudi Arabia pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 UAE pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Kuwait pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 List of key emerging company's/indication disruptors/innovators

Pulsed Field Ablation Market Size & Trends:

The global pulsed field ablation market size was estimated at USD 913.1 million in 2024 and is projected to grow at a CAGR of 33.1% from 2025 to 2030. This is driven by its promise as a safer and more effective alternative to traditional thermal ablation methods. As the global prevalence of atrial fibrillation (AF) rises, there is an increasing demand for innovative treatment options that offer fewer complications and improved outcomes. pulsed field ablation (PFA) non-thermal mechanism significantly reduces the risk of damaging surrounding tissues, a major limitation of conventional ablation techniques like radiofrequency and cryoablation. This unique advantage has led to growing interest from healthcare providers and patients, accelerating its adoption in clinical settings.

Cardiac arrhythmias, particularly atrial fibrillation (AF), are increasingly prevalent, affecting millions worldwide. AF, characterized by an irregular and often rapid heart rate, is the most common type of sustained arrhythmia, significantly raising the risk of stroke, heart failure, and other serious cardiovascular complications. As global populations age and the incidence of lifestyle-related risk factors, such as hypertension and obesity, rises, the number of AF cases continues to grow. According to the Johnson & Johnson Services, Inc. article published in February 2024, more than 37.5 million people globally live with this condition, emphasizing its widespread impact. The risk of developing AFib is notably high; statistics reveal that about one in four adults over the age of 40 experience this arrhythmia at some point in their lives. This growing prevalence highlights the urgent need for effective management and prevention strategies.

This escalating burden has created a substantial demand for effective, minimally invasive treatment options. Traditional therapies such as antiarrhythmic drugs and catheter-based ablation have limitations, leading to an unmet need for safer, more efficient approaches. The increasing prevalence of arrhythmias is thus a key driver of market growth for advanced treatment technologies like pulsed field ablation (PFA), which offer improved safety profiles and efficacy compared to conventional methods. In February 2024, an article in The Lancet Regional Health - Europe highlighted that atrial fibrillation (AF) affects 1.5-2% of European adults, expected to rise to 9.5% in those over 65 by 2060. AF is a significant risk factor for stroke, dementia, heart failure, and premature mortality, posing challenges for the aging population and healthcare systems.

Technological advancements are a key driver of the PFA industry's growth, as ongoing innovations enhance ablation procedures precision, safety, and efficacy. Leading medical device companies are investing heavily in the development of next-generation PFA systems, focusing on improving energy delivery, catheter design, and procedural efficiency. Innovations in catheter flexibility and the integration of real-time imaging and mapping technologies allow for more targeted and controlled ablation, reducing the risk of complications and improving patient outcomes. In October 2024, Abbott announced important advancements in its pulsed field ablation technologies for electrophysiology. The company finished enrolling participants in the VOLT-AF IDE Study aimed at evaluating the Volt PFA System and initiated the FOCALFLEX trial to test the TactiFlex Duo Ablation Catheter for treating paroxysmal atrial fibrillation. These initiatives mark significant progress for Abbott's PFA catheters.

Regulatory approvals are critical in influencing the PFA industry, as they validate the safety and efficacy of these novel devices, paving the way for broader clinical adoption. In recent years, several PFA systems have received CE marking in Europe, allowing them to be marketed and used across the continent. These approvals are often based on positive clinical trial results that demonstrate the benefits of PFA over traditional methods, particularly in terms of reduced procedure times and fewer complications. In October 2024, Medtronic received FDA approval for the Affera Mapping and Ablation System with Sphere-9 Catheter, designed for persistent atrial fibrillation and atrial flutter treatment. This makes Medtronic the first company with two FDA-approved pulsed-field ablation (PFA) technologies for AFib. The Sphere-9 catheter offers flexible treatment options with its 9mm lattice tip, complementing the PulseSelect PFA System, which provides a single-shot solution for pulmonary vein isolation.

Global Pulsed Field Ablation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pulsed field ablation market report based on the components, indication, end use, and region.

• Components Outlook (Revenue, USD Million, 2018 - 2030)
• Catheters
• Generators
• Indication Outlook (Revenue, USD Million, 2018 - 2030)
• Atrial Fibrillation
• Non-atrial Fibrillation
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Inpatient Facilities
• Outpatient Facilities
• Regional Outlook (Revenue, USD Million; 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Components
  • 1.2.2. Indication
  • 1.2.3. End use
  • 1.2.4. Regional Scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Components outlook
  • 2.2.2. Indication outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Pulsed Field Ablation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of cardiac arrhythmias
    • 3.2.1.2. Technological advancements in PFA devices
    • 3.2.1.3. Minimally invasive nature of PFA
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High costs of PFA devices and procedures
    • 3.2.2.2. Lack of long-term data on effectiveness and safety
• 3.3. Pulsed Field Ablation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Pulsed Field Ablation Market: Components Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Pulsed Field Ablation Market: Components Movement Analysis
• 4.3. Pulsed Field Ablation Market by Components Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Catheters
  • 4.5.1. Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Generators
  • 4.6.1. Generators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pulsed Field Ablation Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Pulsed Field Ablation Market: Indication Movement Analysis
• 5.3. Pulsed Field Ablation Market by Indication Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Atrial Fibrillation
  • 5.5.1. Atrial Fibrillation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Non-Atrial Fibrillation
  • 5.6.1. Non-Atrial Fibrillation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pulsed Field Ablation Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Pulsed Field Ablation Market: End Use Movement Analysis
• 6.3. Pulsed Field Ablation Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Inpatient Facilities
  • 6.5.1. Inpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Outpatient Facilities
  • 6.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pulsed Field Ablation Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Boston Scientific Corporation
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Abbott
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Medtronic
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Biosense Webster, Inc. (Johnson & Johnson Services, Inc)
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Pulse Biosciences, Inc
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Kardium
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Jia Jing Electronic Co., Ltd.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Adagio Medical Inc
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. CardioFocus
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Acutus Medical, Inc
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives